Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2223-2229

  Vantyghem, M C ^a,b   Vincent Desplanques, D ^a   Defrance Faivre, F ^a   Capeau, J ^c,d,e   Fermon, C ^a   Valat, A S ^f   Lascols, O ^c,d   Hecart, A C ^g   Pigny, P ^a   Delemer, B ^g   Vigouroux, C ^c,d,e   Wemeau, J L ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut National de la Santéet de la Recherche Médicale U859   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e HÔPITAL TENON   (France)

^f General Hospital   (France)

^g REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN A; LAMIN C; LEPTIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ECLAMPSIA; FAMILIAL PARTIAL LIPODYSTROPHY; FEMALE; FEMALE INFERTILITY; FETUS DEATH; FOLLOW UP; GENE MUTATION; HUMAN; LIVE BIRTH; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

EID: 45349087575     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2521     Document Type: Article

References (45)

1. Garg A 2004 Acquired and inherited lipodystrophies. N Engl J Med 350: 1220-1234
2. Worman HJ, Bonne G 2007 "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 313:2121-2133
3. Decaudain A, Vantyghem MC, Guerci B, Hecart AC, Auclair M, Reznik Y, Narbonne H, Ducluzeau PH, Donadille B, Lebbe C, Bereziat V, Capeau J, Lascols O, Vigouroux C 2007 New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 92:4835-4844
4. Young J, Morbois-Trabut L, Couzinet B, Lascols O, Dion E, Béréziat V, Fève B, Richard I, Capeau J, Chanson P, Vigouroux C 2005 Type A insulin resistance syndrome revealing a novel lamin A mutation. Diabetes 54:1873-1878
5. Sathanantan A, Babovic D, Erickson D Dunnigan's partial lipodystrophy originally diagnosed as polycystic ovary syndrome. Program of the 89th Annual Meeting of The Endocine Society, Toronto, Canada, June 2-5, 2007
6. Haxton MJ 1983 Progressive partial lipodystrophy in association with intrauterine death and growth retardation. Am J Obstet Gynecol 147:837-838
7. Fitch N, Tulandi T 1987 Progressive partial lipodystrophy and third-trimester intrauterine fetal death. Am J Obstet Gynecol 156:1195-1196
8. Thivolet CH, Mauduit G, Canivet B, Garrel D, Tourniaire J, Thivolet J, Pugeat M 1988 Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia. Presse Med 17:1355-1359
9. Panchal R, Bosio P, Waugh J 2005 Familial partial lipodystrophy complicated by pre-eclampsia. J Obstet Gynaecol 25:196-197
10. Davis 3rd AE, Arnaout MA, Alper CA, Rosen FS 1977 Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med 297: 144-145
11. Bennett WM, Fassett RG, Walker RG, Fairley KF, d'Apice AJ, Kincaid-Smith P 1989 Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease. Am J Kidney Dis 13:469-476
12. Demetriou K, Kallikas I, Zouvani I, Kyriacou K, Pierides A 1998 The pregnant patient with partial lipodystrophy developing acute renal failure - onset of de novo membranoproliferative glomerulonephritis. Nephrol Dial Transplant 13:2121-2124
13. Russell JG 1958 Lipodystrophy progressiva and pregnancy. Postgrad Med J 34:530
14. Catalano PM, Capeless EL, Simmons GM, Robbins DC, Horton ES 1990 Successful pregnancy outcome in association with lipoatrophic diabetes mellitus. Obstet Gynecol 76(5 Pt 2):978-979
15. Sturley RH, Stirling C, Reckless JP 1994 Generalised lipodystrophy and pregnancy. Br J Obstet Gynaecol 101:719-720
16. Akhter J, Qureshi R 1995 Partial lipodystrophy and successful pregnancy outcome. J Pak Med Assoc 45:24
17. Dolberg BK, Lenhard MJ 2000 Successful outcome of pregnancy in a patient with generalized lipoatrophic diabetes mellitus. Endocr Pract 6:34-36
18. Morse AN, Whitaker MD 2000 Successful pregnancy in a woman with lipoatrophic diabetes mellitus. A case report. J Reprod Med 45:850-852
19. Vantyghem MC, Faivre-Defrance F, Marcelli-Tourvieille S, Fermon C, Evrard A, Bourdelle-Hego MF, Vigouroux C, Defebvre L, Delemer B, Wemeau JL 2007 Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Clin Endocrinol (Oxf) 67:247-249
20. Forti G, Krausz C 1998 Evaluation and treatment of the infertile couple. J Clin Endocrinol Metab 83:4177-4188
21. Gray RH, Simpson JL, Kambic RT, Queenan JT, Mena P, Perez A, Barbato M 1995 Timing of conception and the risk of spontaneous abortion among pregnancies occurring during the use of natural family planning. Am J Obstet Gynecol 172:1567-1572
22. Buss L, Tolstrup J, Munk C, Bergholt T, Ottesen B, Gronbaek M, Kjaer SK 2006 Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants. Acta Obstet Gynecol Scand 85:467-475
23. Sermer M, Naylor CD, Farine D, Kenshole AB, Ritchie JW, Gare DJ, Cohen HR, McArthur K, Holzapfel S, Biringer A 1998 The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care Suppl 2:B33-B42
24. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
25. Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J 2003 Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 18:1438-1441
26. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS 2006 A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12:673-683
27. Kjos MD, Buchanan TA, Siri L 1999 Gestational diabetes mellitus. N Engl J Med 341:1749-1756
28. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS 1995 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10:2107-2111
29. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER 2007 Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 8:356:551-566
30. Palomba S, Orio Jr F, Falbo A, Russo T, Tolino A, Zullo F 2007 Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. J Clin Endocrinol Metab 92:3498-3503
31. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A 2001 Obstetric outcome inwomenwith polycystic ovarian syndrome. Hum Reprod 16:226-229
32. Jonasson JM, Brismar K, Sparén K, Lambe M, Nyrén O, Östenson CG, Ye W 2007 Fertility in women with type 1 diabetes mellitus. A population-based cohort study in Sweden. Diabetes Care 30:2271-2276
33. Otani H, Tanaka O, Tatewaki R, Naora H, Yoneyama T 1991 Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40:1245-1250
34. Vantyghem MC, Vigouroux C, Magre J, Desbois-Mouthon C, Pattou F, Fontaine P, Lefebvre J, Capeau J 1999 Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro insulin analog. Diabetes Care 22:1374-1376
35. Vigouroux C, Magre J, Vantyghem MC, Bourut C, Lascols O, Shackleton S, Lloyd DJ, Guerci B, Padova G, Valensi P, Grimaldi A, Piquemal R, Touraine P, Trembath RC, Capeau J 2000 Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 49:1958-1962
36. Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, Bryer-Ash M, Rich SS, Bowden DW, Sale MM 2007 Association of the estrogen receptor α gene with the metabolic syndrome and its component traits in African American families: The IRAS Family Study. Diabetes 56:2135-2141
37. Gowri PM, Sengupta S, Bertera S, Katzenellenbogen BS 2007 Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility. Endocrinology 148:3685-3693
38. Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Genevieve D, Hadj-Rabia S, Gaudy-Marqueste C, Smitt HS, Vabres P, Faivre L, Verloes A, Van Essen T, Flori E, Hennekam R, Beemer FA, Laurent N, Le Merrer M, Cau P, Levy N 2004 Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 13:2493-2503
39. Musso C, Cochran E, Javor E, Young J, Depaoli AM, Gorden P 2005 The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism 54:255-263
40. Li MG, Ding GL, Chen XJ, Lu XP, Dong LJ, Dong MY, Yang XF, Lu XE, Huang HF 2007 Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab 92:4771-4776
41. Iuorno MJ, Islam LZ, Veldhuis PP, Boyd DG, Farhy LS, Johnson ML, Nestler JE, Evans WS 2007 Leptin secretory burst mass correlates with body mass index and insulin in normal women but not in women with polycystic ovary syndrome. Metabolism 56:1561-1565
42. Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S, McCarthy MI 2008 Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome. J Clin Endocrinol Metab 93: 999-1004
43. Al-Attar SA, Pollex RL, Robinson JF, Miskie BA, Walcarius R, Little CH, Rutt BK, Hegele RA 2007 Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging. BMC Med Imaging 7:3
44. Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC 2006 Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study. Hum Reprod 21:1400-1407
45. Solano ME, Elia E, Luchetti CG, Sander V, Di Girolamo G, Gonzalez C, Motta AB 2006 Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice. Reprod Fertil Dev 18: 533-544